Milestone Operating Income vs Research Development Analysis

MLSS Stock

USD 0.72 0.09 11.11%

Milestone Scientific financial indicator trend analysis is infinitely more than just investigating Milestone Scientific recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Milestone Scientific is a good investment. Please check the relationship between Milestone Scientific Operating Income and its Research Development accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Milestone Scientific. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

For more information on how to buy Milestone Stock please use our How to Invest in Milestone Scientific guide.

Operating Income vs Research Development

Operating Income vs Research Development Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Milestone Scientific Operating Income account and Research Development. At this time, the significance of the direction appears to have strong contrarian relationship.

The correlation between Milestone Scientific's Operating Income and Research Development is -0.65. Overlapping area represents the amount of variation of Operating Income that can explain the historical movement of Research Development in the same time period over historical financial statements of Milestone Scientific, assuming nothing else is changed. The correlation between historical values of Milestone Scientific's Operating Income and Research Development is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Operating Income of Milestone Scientific are associated (or correlated) with its Research Development. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Research Development has no effect on the direction of Operating Income i.e., Milestone Scientific's Operating Income and Research Development go up and down completely randomly.

Correlation Coefficient

-0.65

Relationship Direction	Negative
Relationship Strength	Weak

View All Relationships

Operating Income

Operating Income is the amount of profit realized from Milestone Scientific operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Milestone Scientific is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.

Research Development

Most indicators from Milestone Scientific's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Milestone Scientific current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Milestone Scientific. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

For more information on how to buy Milestone Stock please use our How to Invest in Milestone Scientific guide.At this time, Milestone Scientific's Issuance Of Capital Stock is comparatively stable compared to the past year. Sales General And Administrative To Revenue is likely to gain to 1.51 in 2024, whereas Selling General Administrative is likely to drop slightly above 8.5 M in 2024.

	2021	2022	2023	2024 (projected)
Gross Profit	6.3M	4.9M	6.7M	4.5M
Total Revenue	10.3M	8.8M	9.8M	7.9M

Gross Profit Total Revenue

Milestone Scientific fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Inventory	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Intangible Assets	Other Current Assets	Common Stock Total Equity	Non Current Liabilities Total	Common Stock
Total Assets		0.25	0.38	0.07	0.94	0.62	-0.9	-0.42	-0.36	0.89	-0.28	-0.42	0.89	0.2	0.45	0.51	0.61	0.14	0.27	0.98	-0.04	-0.08	-0.39	0.42	-0.26	0.42
Short Long Term Debt Total	0.25		0.02	-0.27	0.29	0.58	-0.4	-0.35	-0.08	0.45	-0.03	0.39	0.47	-0.53	0.43	-0.37	0.36	-0.14	0.3	0.23	-0.35	-0.37	-0.14	0.41	-0.11	0.41
Other Current Liab	0.38	0.02		0.56	0.21	0.26	-0.33	-0.66	-0.33	0.32	-0.54	-0.32	0.34	0.35	0.58	0.34	0.74	0.55	0.23	0.48	0.08	-0.13	-0.48	0.57	0.16	0.57
Total Current Liabilities	0.07	-0.27	0.56		-0.25	-0.34	0.23	-0.29	0.29	-0.24	-0.01	-0.23	-0.25	0.81	0.05	0.45	0.29	0.98	-0.23	0.07	0.6	0.24	-0.52	0.05	-0.05	0.03
Total Stockholder Equity	0.94	0.29	0.21	-0.25		0.71	-0.94	-0.32	-0.42	0.94	-0.32	-0.36	0.94	-0.06	0.4	0.4	0.51	-0.18	0.32	0.94	-0.2	-0.19	-0.24	0.37	-0.27	0.38
Property Plant And Equipment Net	0.62	0.58	0.26	-0.34	0.71		-0.75	-0.47	-0.6	0.77	-0.45	-0.24	0.8	-0.37	0.69	0.07	0.52	-0.24	0.62	0.66	-0.25	-0.23	0.07	0.67	0.03	0.68
Net Debt	-0.9	-0.4	-0.33	0.23	-0.94	-0.75		0.39	0.48	-1.0	0.39	0.32	-0.98	0.19	-0.49	-0.21	-0.57	0.17	-0.35	-0.91	0.24	0.29	0.24	-0.46	0.19	-0.47
Retained Earnings	-0.42	-0.35	-0.66	-0.29	-0.32	-0.47	0.39		0.21	-0.41	0.69	0.38	-0.47	-0.1	-0.93	-0.22	-0.89	-0.34	-0.64	-0.52	0.07	0.58	0.68	-0.92	0.38	-0.92
Accounts Payable	-0.36	-0.08	-0.33	0.29	-0.42	-0.6	0.48	0.21		-0.47	0.35	0.13	-0.49	0.12	-0.44	0.01	-0.26	0.22	-0.33	-0.4	0.13	-0.15	-0.24	-0.45	-0.39	-0.45
Cash	0.89	0.45	0.32	-0.24	0.94	0.77	-1.0	-0.41	-0.47		-0.39	-0.31	0.99	-0.22	0.52	0.18	0.58	-0.17	0.37	0.9	-0.26	-0.31	-0.24	0.48	-0.19	0.49
Non Current Assets Total	-0.28	-0.03	-0.54	-0.01	-0.32	-0.45	0.39	0.69	0.35	-0.39		0.41	-0.43	0.04	-0.7	-0.37	-0.62	0.05	-0.48	-0.47	-0.08	0.66	0.34	-0.71	0.29	-0.71
Non Currrent Assets Other	-0.42	0.39	-0.32	-0.23	-0.36	-0.24	0.32	0.38	0.13	-0.31	0.41		-0.32	-0.3	-0.37	-0.44	-0.39	-0.2	-0.21	-0.47	-0.09	0.13	0.19	-0.37	0.17	-0.37
Cash And Short Term Investments	0.89	0.47	0.34	-0.25	0.94	0.8	-0.98	-0.47	-0.49	0.99	-0.43	-0.32		-0.21	0.58	0.2	0.64	-0.19	0.43	0.91	-0.29	-0.34	-0.25	0.55	-0.21	0.56
Net Receivables	0.2	-0.53	0.35	0.81	-0.06	-0.37	0.19	-0.1	0.12	-0.22	0.04	-0.3	-0.21		-0.11	0.72	0.15	0.78	-0.32	0.18	0.63	0.42	-0.42	-0.09	-0.1	-0.11
Common Stock Shares Outstanding	0.45	0.43	0.58	0.05	0.4	0.69	-0.49	-0.93	-0.44	0.52	-0.7	-0.37	0.58	-0.11		0.09	0.8	0.13	0.78	0.54	-0.23	-0.51	-0.4	0.99	-0.18	1.0
Inventory	0.51	-0.37	0.34	0.45	0.4	0.07	-0.21	-0.22	0.01	0.18	-0.37	-0.44	0.2	0.72	0.09		0.32	0.4	-0.07	0.56	0.51	0.08	-0.41	0.11	-0.33	0.09
Other Stockholder Equity	0.61	0.36	0.74	0.29	0.51	0.52	-0.57	-0.89	-0.26	0.58	-0.62	-0.39	0.64	0.15	0.8	0.32		0.31	0.49	0.7	-0.02	-0.51	-0.69	0.77	-0.37	0.77
Total Liab	0.14	-0.14	0.55	0.98	-0.18	-0.24	0.17	-0.34	0.22	-0.17	0.05	-0.2	-0.19	0.78	0.13	0.4	0.31		-0.14	0.12	0.53	0.31	-0.5	0.13	0.0	0.11
Property Plant And Equipment Gross	0.27	0.3	0.23	-0.23	0.32	0.62	-0.35	-0.64	-0.33	0.37	-0.48	-0.21	0.43	-0.32	0.78	-0.07	0.49	-0.14		0.33	-0.37	-0.35	-0.06	0.75	-0.13	0.78
Total Current Assets	0.98	0.23	0.48	0.07	0.94	0.66	-0.91	-0.52	-0.4	0.9	-0.47	-0.47	0.91	0.18	0.54	0.56	0.7	0.12	0.33		-0.01	-0.21	-0.43	0.51	-0.29	0.52
Short Term Debt	-0.04	-0.35	0.08	0.6	-0.2	-0.25	0.24	0.07	0.13	-0.26	-0.08	-0.09	-0.29	0.63	-0.23	0.51	-0.02	0.53	-0.37	-0.01		0.26	-0.2	-0.24	-0.25	-0.25
Intangible Assets	-0.08	-0.37	-0.13	0.24	-0.19	-0.23	0.29	0.58	-0.15	-0.31	0.66	0.13	-0.34	0.42	-0.51	0.08	-0.51	0.31	-0.35	-0.21	0.26		0.48	-0.49	0.61	-0.49
Other Current Assets	-0.39	-0.14	-0.48	-0.52	-0.24	0.07	0.24	0.68	-0.24	-0.24	0.34	0.19	-0.25	-0.42	-0.4	-0.41	-0.69	-0.5	-0.06	-0.43	-0.2	0.48		-0.36	0.69	-0.36
Common Stock Total Equity	0.42	0.41	0.57	0.05	0.37	0.67	-0.46	-0.92	-0.45	0.48	-0.71	-0.37	0.55	-0.09	0.99	0.11	0.77	0.13	0.75	0.51	-0.24	-0.49	-0.36		-0.14	1.0
Non Current Liabilities Total	-0.26	-0.11	0.16	-0.05	-0.27	0.03	0.19	0.38	-0.39	-0.19	0.29	0.17	-0.21	-0.1	-0.18	-0.33	-0.37	0.0	-0.13	-0.29	-0.25	0.61	0.69	-0.14		-0.14
Common Stock	0.42	0.41	0.57	0.03	0.38	0.68	-0.47	-0.92	-0.45	0.49	-0.71	-0.37	0.56	-0.11	1.0	0.09	0.77	0.11	0.78	0.52	-0.25	-0.49	-0.36	1.0	-0.14

Click cells to compare fundamentals

Milestone Scientific Account Relationship Matchups

Milestone Scientific fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	6.6M	19.6M	19.8M	13.7M	11.4M	9.5M
Other Current Liab	3.2M	1.8M	2.2M	2.1M	1.9M	1.0M
Total Current Liabilities	4.9M	2.9M	3.1M	3.3M	3.1M	3.1M
Total Stockholder Equity	1.7M	16.2M	16.4M	10.2M	8.0M	5.7M
Property Plant And Equipment Net	45.0K	663.2K	574.2K	479.5K	374.3K	308.7K
Net Debt	(1.5M)	(13.3M)	(14.2M)	(8.2M)	(2.6M)	(2.7M)
Retained Earnings	(93.5M)	(100.9M)	(107.7M)	(116.4M)	(123.3M)	(117.2M)
Accounts Payable	1.4M	483.0K	780.4K	1.1M	1.1M	1.5M
Cash	1.5M	14.2M	14.8M	8.7M	3.0M	3.4M
Non Current Assets Total	463.1K	1.0M	876.0K	731.6K	577.0K	548.2K
Cash And Short Term Investments	1.5M	14.2M	14.8M	8.7M	6.0M	3.5M
Net Receivables	1.7M	1.1M	943.3K	693.7K	1.7M	1.2M
Common Stock Shares Outstanding	45.7M	63.1M	68.8M	70.6M	72.8M	76.4M
Liabilities And Stockholders Equity	6.6M	19.6M	19.8M	13.7M	11.4M	9.5M
Inventory	1.6M	2.4M	1.5M	1.8M	2.6M	1.7M
Other Stockholder Equity	95.2M	117.0M	124.0M	126.6M	131.3M	72.6M
Total Liab	4.9M	3.5M	3.6M	3.7M	3.4M	3.9M
Property Plant And Equipment Gross	45.0K	30.7K	1.5M	1.4M	1.3M	1.4M
Total Current Assets	6.1M	18.6M	18.9M	13.0M	10.8M	7.7M
Short Term Debt	16.0K	356.0K	89.5K	101.1K	113.7K	108.0K
Intangible Assets	382.3K	329.2K	277.6K	228.0K	178.6K	169.7K
Other Current Assets	535.0K	415.9K	375.4K	443.9K	517.8K	628.5K
Common Stock Total Equity	34.6K	36.3K	49.4K	64.2K	73.8K	77.5K
Non Current Liabilities Total	1.7M	586.6K	497.0K	396.0K	282.3K	268.2K
Common Stock	49.4K	64.2K	68.2K	69.3K	75.9K	79.7K
Other Assets	26.9K	35.9K	687.3K	24.2K	0.9	0.86
Property Plant Equipment	82.6K	45.0K	663.2K	574.2K	516.8K	542.6K
Current Deferred Revenue	2.5M	521.8K	340.5K	242.6K	279.0K	495.5K
Net Tangible Assets	1.1M	1.3M	15.9M	16.1M	18.5M	19.4M
Noncontrolling Interest In Consolidated Entity	256.7K	(11.4K)	(67.3K)	(94.4K)	(85.0K)	(89.2K)
Retained Earnings Total Equity	(78.6M)	(86.0M)	(93.5M)	(100.9M)	(90.8M)	(95.3M)
Capital Surpluse	86.7M	88.4M	96.1M	117.9M	135.6M	90.5M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Milestone Stock Analysis

When running Milestone Scientific's price analysis, check to measure Milestone Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Milestone Scientific is operating at the current time. Most of Milestone Scientific's value examination focuses on studying past and present price action to predict the probability of Milestone Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Milestone Scientific's price. Additionally, you may evaluate how the addition of Milestone Scientific to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC